Figure S7. Gli1-creERT-mediated DTA expression inhibited injury-induced HO. A&B) Typical x-ray images of control (A) and TAM treated (B) Nse-BMP4;Gli-creERT;ROSA26-eGFP-DTA mice after injury. C) HO incidence in control and TAM treated group. D) Quantification of wet weight of HO in the control and TAM treated groups. Note that depletion of Gli1-creERT-labeled cells partially inhibited but did not completely block HO. E) Typical fluorescence images from TAM treated (E) and control (F) Nse-BMP4;Gli1-creERT;ROSA26-eGFP-DTA mice. Note that in the TAM treated group (E), GFP- (recombined) cells were rarely found. G&H) H&E staining of sections from TAM treated (G) and control (H) Nse-BMP4;Gli1-creERT;ROSA26-eGFP-DTA mice. Note that both fluorescen...
Figure S2. Representative H&E images of 8 patients with aHO. The number in each panel is the patient...
Figure S3. The bone regeneration in the four groups on day 28 after operation. A The newly formed bo...
Abstract Background Heterotopic ossification (HO), either acquired (aHO) or hereditary, such as fibr...
Figure S6. Conditional depletion of Glast-creERT+ cells resulted in less severe yet “typical” HO. A&...
Figure S8. Evidence of depletion of Gli1 in the target cells. The depletion of Gli1 in the target ce...
Table S3. Summary of the histomorphometric analysis of Nse-BMP4;Glast-creERT;ROSA26-eGFP-DTA mice wi...
Figure S5. The distribution of Cre-labeled cells outside of the target regions. A&B) the distributio...
Figure S9. Characterization of candidate niche supportive ECM molecules. A) Col4 was mainly involved...
Figure S4. LRC cells co-labeled with typical MSC markers. In the early stages of the lesion (A&C), a...
Figure S10. Working model of injury-induced MSC niche. Injury-induced local microenvironment (MSC ni...
Figure S3. Validation of the dual-pulse CldU and IdU labeling procedure. To validate this procedure,...
Figure S1. The bone regeneration in the four groups on day 7 after operation. A–B HE staining (A) an...
Cell surface markers and differentiation capacities of mouse MSCs. (A) Flow cytometry analysis resul...
Figure S2. The bone regeneration in the four groups on day 14 after operation. A HE staining of the ...
Figure S1. Representative X-ray/CT images of 8 patients with aHO. The number in each panel is the pa...
Figure S2. Representative H&E images of 8 patients with aHO. The number in each panel is the patient...
Figure S3. The bone regeneration in the four groups on day 28 after operation. A The newly formed bo...
Abstract Background Heterotopic ossification (HO), either acquired (aHO) or hereditary, such as fibr...
Figure S6. Conditional depletion of Glast-creERT+ cells resulted in less severe yet “typical” HO. A&...
Figure S8. Evidence of depletion of Gli1 in the target cells. The depletion of Gli1 in the target ce...
Table S3. Summary of the histomorphometric analysis of Nse-BMP4;Glast-creERT;ROSA26-eGFP-DTA mice wi...
Figure S5. The distribution of Cre-labeled cells outside of the target regions. A&B) the distributio...
Figure S9. Characterization of candidate niche supportive ECM molecules. A) Col4 was mainly involved...
Figure S4. LRC cells co-labeled with typical MSC markers. In the early stages of the lesion (A&C), a...
Figure S10. Working model of injury-induced MSC niche. Injury-induced local microenvironment (MSC ni...
Figure S3. Validation of the dual-pulse CldU and IdU labeling procedure. To validate this procedure,...
Figure S1. The bone regeneration in the four groups on day 7 after operation. A–B HE staining (A) an...
Cell surface markers and differentiation capacities of mouse MSCs. (A) Flow cytometry analysis resul...
Figure S2. The bone regeneration in the four groups on day 14 after operation. A HE staining of the ...
Figure S1. Representative X-ray/CT images of 8 patients with aHO. The number in each panel is the pa...
Figure S2. Representative H&E images of 8 patients with aHO. The number in each panel is the patient...
Figure S3. The bone regeneration in the four groups on day 28 after operation. A The newly formed bo...
Abstract Background Heterotopic ossification (HO), either acquired (aHO) or hereditary, such as fibr...